271 related articles for article (PubMed ID: 15609684)
41. Rituximab for the treatment of childhood chronic idiopathic thrombocytopenic purpura and hemophilia with inhibitors.
Franchini M; Zaffanello M; Veneri D; Lippi G
Pediatr Blood Cancer; 2007 Jul; 49(1):6-10. PubMed ID: 17311349
[TBL] [Abstract][Full Text] [Related]
42. Management of adult idiopathic thrombocytopenic purpura.
Nakhoul IN; Kozuch P; Varma M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
[TBL] [Abstract][Full Text] [Related]
43. Current options for the treatment of idiopathic thrombocytopenic purpura.
Arnold DM; Kelton JG
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
[TBL] [Abstract][Full Text] [Related]
44. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.
Stasi R; Pagano A; Stipa E; Amadori S
Blood; 2001 Aug; 98(4):952-7. PubMed ID: 11493438
[TBL] [Abstract][Full Text] [Related]
45. Consolidation treatment with rituximab induces complete and persistent remission of mixed type Evans syndrome.
Rodella E; Pacquola E; Bianchini E; Ramazzina E; Paolini R
Blood Coagul Fibrinolysis; 2008 Jun; 19(4):315-8. PubMed ID: 18469554
[TBL] [Abstract][Full Text] [Related]
46. Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood.
Taube T; Schmid H; Reinhard H; von Stackelberg A; Overberg US
Haematologica; 2005 Feb; 90(2):281-3. PubMed ID: 15710595
[TBL] [Abstract][Full Text] [Related]
47. [Refractory idiopathic thrombocytopenic purpura following influenza vaccination].
Tsuji T; Yamasaki H; Tsuda H
Rinsho Ketsueki; 2009 Jul; 50(7):577-9. PubMed ID: 19638727
[TBL] [Abstract][Full Text] [Related]
48. Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.
Millward PM; Bandarenko N; Chang PP; Stagg KF; Afenyi-Annan A; Hay SN; Brecher ME
Transfusion; 2005 Sep; 45(9):1481-6. PubMed ID: 16131381
[TBL] [Abstract][Full Text] [Related]
49. Aplastic anemia successfully treated with rituximab.
Hansen PB; Lauritzen AM
Am J Hematol; 2005 Dec; 80(4):292-4. PubMed ID: 16315256
[TBL] [Abstract][Full Text] [Related]
50. Does rituximab aggravate pre-existing hypogammaglobulinaemia?
Diwakar L; Gorrie S; Richter A; Chapman O; Dhillon P; Al-Ghanmi F; Noorani S; Krishna MT; Huissoon A
J Clin Pathol; 2010 Mar; 63(3):275-7. PubMed ID: 20203231
[TBL] [Abstract][Full Text] [Related]
51. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
Gómez-Almaguer D
Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772
[TBL] [Abstract][Full Text] [Related]
52. Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
Medeot M; Zaja F; Vianelli N; Battista M; Baccarani M; Patriarca F; Soldano F; Isola M; De Luca S; Fanin R
Eur J Haematol; 2008 Sep; 81(3):165-9. PubMed ID: 18510702
[TBL] [Abstract][Full Text] [Related]
53. [Three cases of idiopathic thrombocytopenic purpura showing an increase in the platelet count following clarithromycin treatment].
Ohe M; Kohno M
Rinsho Ketsueki; 2003 Oct; 44(10):1044-6. PubMed ID: 14639954
[TBL] [Abstract][Full Text] [Related]
54. [A case of adult idiopathic thrombocytopenic purpura associated with atypical mumps virus infection].
Hayashi K; Kawada E; Shinonome S
Rinsho Ketsueki; 1997 Aug; 38(8):696-8. PubMed ID: 9311277
[TBL] [Abstract][Full Text] [Related]
55. Classical management of refractory adult immune (idiopathic) thrombocytopenic purpura.
McMillan R
Blood Rev; 2002 Mar; 16(1):51-5. PubMed ID: 11913996
[TBL] [Abstract][Full Text] [Related]
56. Quantitative comparisons of antibody-binding sites of platelet glycoprotein IIb/IIIa in aplastic anemia and idiopathic thrombocytopenic purpura.
Kahng J; Park HH; Han K; Choi BY; Lee W
Ann Clin Lab Sci; 2008; 38(1):6-11. PubMed ID: 18316775
[TBL] [Abstract][Full Text] [Related]
57. Rituximab in the treatment of autoimmune haematological disorders.
Garvey B
Br J Haematol; 2008 Apr; 141(2):149-69. PubMed ID: 18318765
[TBL] [Abstract][Full Text] [Related]
58. The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura.
Sikorska A; Konopka L; Maślanka K
Int J Lab Hematol; 2008 Feb; 30(1):58-64. PubMed ID: 18190469
[TBL] [Abstract][Full Text] [Related]
59. Critical issues of current and future developments in the treatment of immune thrombocytopenic purpura.
Koene HR
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):703-5. PubMed ID: 16933273
[TBL] [Abstract][Full Text] [Related]
60. Central nervous system inflammatory demyelination after rituximab therapy for idiopathic thrombocytopenic purpura.
Stübgen JP
J Neurol Sci; 2010 Jan; 288(1-2):178-81. PubMed ID: 19897212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
